Having shown that SHP2 inhibitors induced cell death in vitro, we further evaluated the anti-myeloma efficacy of SHP2 inhibitors in vivo by using MM murine xenograft models developed by subcutaneous injection of RPMI-8226 cells into the left flank of the Balb/c nude mice. The gene discussed is PTPN11; the disease is plasma cell myeloma.